Diversity one year later: How pharmaceutical companies can plan their diversity strategies now May 10 | Webinar
Event
May 10, 2023
This Event Has Ended
It has been one year since the US FDA issued their updated draft guidance for the industry on developing plans to increase racial and ethnic diversity in clinical trials. How have pharmaceutical companies changed their clinical trial strategies since then, and how can they set themselves up for success?
Join this virtual event where we will discuss regulators’ growing expectations of pharmaceutical companies around diversity, and the state of diversity in clinical trials today. We will also share steps to take to optimize selection of sites that will enroll diverse populations and more confidently set up diversity goals and action plans for clinical trials.
You will learn:
- What new regulations, including the Consolidated Appropriation Act, 2023, means for diversity requirements in clinical trials
- How to build an evidence-based diversity action plan for FDA submission
- What data and insights you can leverage to achieve greater enrollment of diverse populations